Literature DB >> 9403716

Organ-site dependence for the production of urokinase-type plasminogen activator and metastasis by human renal cell carcinoma cells.

K Gohji1, M Nakajima, D Boyd, C P Dinney, C D Bucana, S Kitazana, S Kamidono, I J Fidler.   

Abstract

We examined the role of urokinase-type plasminogen activator (u-PA) in the metastasis of the human renal cell carcinoma (HRCC) implanted in athymic nude mice. Cells from a HRCC KG-2 line were implanted in orthotopic (kidney) and ectopic (subcutaneous) organs. The KG-2 cells implanted in the kidney produced local tumors and lung metastases, whereas those implanted subcutaneously produced only local tumors. The production of u-PA was determined by immunohistochemistry and an enzyme-linked immunosorbent assay (ELISA). High levels of u-PA were produced by the metastatic kidney tumors and lung metastases, whereas the subcutaneous tumors produced low levels. KG-2 cells co-cultured with mouse kidney or lung fibroblasts produced higher levels of u-PA than KG-2 cells co-cultured with mouse skin fibroblasts. Furthermore, KG-2 cells cultured with the conditioned medium from mouse kidney or lung fibroblasts produced higher levels of u-PA than KG-2 cells cultured with the conditioned medium from mouse skin fibroblasts. The results indicate that the expression of u-PA by KG-2 cells is one of the important factors that determine their metastatic potential and that the production of u-PA is influenced by the organ microenvironment, including soluble factors produced by surrounding fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403716      PMCID: PMC1858342     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Human primary colon carcinomas xenografted into nude mice. II. Modulation of tumor plasminogen activator activity by the host tissue environment.

Authors:  J F Cajot; B Sordat; F Bachmann
Journal:  J Natl Cancer Inst       Date:  1986-11       Impact factor: 13.506

Review 2.  Proteolytic degradation of extracellular matrix in tumor invasion.

Authors:  K Tryggvason; M Höyhtyä; T Salo
Journal:  Biochim Biophys Acta       Date:  1987-11-25

3.  Examination of urokinase protein/transcript levels and their relationship with laminin degradation in cultured colon carcinoma.

Authors:  D Boyd; B Ziober; S Chakrabarty; M Brattain
Journal:  Cancer Res       Date:  1989-02-15       Impact factor: 12.701

4.  Increase of urokinase-type plasminogen activator gene expression in human lung and breast carcinomas.

Authors:  A P Sappino; N Busso; D Belin; J D Vassalli
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

Review 5.  Plasminogen activators, tissue degradation, and cancer.

Authors:  K Danø; P A Andreasen; J Grøndahl-Hansen; P Kristensen; L S Nielsen; L Skriver
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 6.  Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions.

Authors:  S L Schor; A M Schor
Journal:  Bioessays       Date:  1987-11       Impact factor: 4.345

7.  Measurement of urokinase-type plasminogen activator (u-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies.

Authors:  V Darras; M Thienpont; D C Stump; D Collen
Journal:  Thromb Haemost       Date:  1986-12-15       Impact factor: 5.249

8.  Secretion of basement membrane collagen degrading enzyme and plasminogen activator by transformed cells--role in metastasis.

Authors:  T Salo; L A Liotta; J Keski-Oja; T Turpeenniemi-Hujanen; K Tryggvason
Journal:  Int J Cancer       Date:  1982-11-15       Impact factor: 7.396

9.  Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype.

Authors:  F D Gaylis; H N Keer; M J Wilson; H C Kwaan; A A Sinha; J M Kozlowski
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

10.  Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors.

Authors:  M A Collart; D Belin; J D Vassalli; S de Kossodo; P Vassalli
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.

Authors:  Y D Jung; L M Ellis
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

2.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

Authors:  Steve Goodison; Jing Yuan; Derek Sloan; Ryung Kim; Cheng Li; Nicholas C Popescu; Virginia Urquidi
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

Review 3.  Matrix metalloproteinases: changing roles in tumor progression and metastasis.

Authors:  Laurie A Shuman Moss; Sandra Jensen-Taubman; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2012-10-12       Impact factor: 4.307

4.  Seminal Vesicle Tumor Microenvironment.

Authors:  Alessia Cimadamore; Rodolfo Montironi; Sergio Serni; Riccardo Campi
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 5.  The pre-metastatic niche: is metastasis random?

Authors:  Thomas R Cox; Alison Gartland; Janine T Erler
Journal:  Bonekey Rep       Date:  2012-05-02

6.  Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis.

Authors:  F Laube; B Göhring; H Sann; I Willhardt
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

7.  Enhanced progression of human prostate cancer PC3 cells induced by the microenvironment of the seminal vesicle.

Authors:  M Kumano; H Miyake; T Kurahashi; K Yamanaka; M Fujisawa
Journal:  Br J Cancer       Date:  2008-01-08       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.